Double-Blind, Randomized, Phase 3, Comparative Study of a New Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm

Trial Profile

Double-Blind, Randomized, Phase 3, Comparative Study of a New Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Oct 2013

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Blepharospasm
  • Focus Registrational; Therapeutic Use
  • Sponsors Pacific Pharmaceutical
  • Most Recent Events

    • 14 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top